Exicure Inc (XCUR NASDAQ) stock market data APIs
$14.4404
0.26(1.8%)
as of March 21, 2025
Exicure Inc Financial Data Overview
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
Prev. Close
14.177
Open
14.4404
High
14.513
Low
14.177
52 wk Range
1.44-36
Market Cap
88 765 K
Shares Outstanding
6 318 K
Revenue
500 K
EPS
-0.5744
Beta
3.851
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Exicure Inc data using free add-ons & libraries
Get Exicure Inc Fundamental Data
Exicure Inc Fundamental data includes:
- Net Revenue: 500 K
- EBITDA: -4 921 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-27
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Exicure Inc News
New
11 Best Stocks to Buy for the Next 10 Years
In this piece, we will take a look at the 11 best stocks to buy for the next ten years. If you want to skip our take on what's happening in the stock market right now and some future predictions, then...
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update
CHICAGO, July 14, 2023--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic aci...
Exicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic Alternatives
CHICAGO, May 26, 2023--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR) ("Exicure" or the "Company"), historically an early-stage biotechnology company focused on developing nucleic acid therapies target...
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
CHICAGO, May 19, 2023--(BUSINESS WIRE)--Exicure, Inc. ("Exicure" or the "Company") (Nasdaq: XCUR), announced today it received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on May...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
